Wolfgang A Miesbach (Wolfgang Miesbach, W Miesbach)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 35

Top Topics

Venous Thromboembolism

Clinical Practice

Top Venues

Haemophilia : the official journal of the World Federation of Hemophilia

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis

The New England journal of medicine

European journal of haematology

This page only lists publications with an associated author ORCID identifier.

Publications

Wolfgang A Miesbach
Which patients should be considered for gene therapy. Journal of viral hepatitis (2024)
Wolfgang A Miesbach, Manuel D Carcao, Johnny N Mahlangu, Yesim Dargaud, Victor Jimenez-Yuste, Cédric Hermans
Eptacog beta for the management of patients with haemophilia A and B with inhibitors: A European perspective. Haemophilia : the official journal of the World Federation of Hemophilia 30 (2) (2024)
Wolfgang A Miesbach, Ana Boban, Pratima Chowdary, Michiel Coppens, Miguel Crato, Victor Jimenez Yuste, Robert Klamroth, Michael P Makris, Greta Mulders, Flora Peyvandi
EAHAD haemophilia gene therapy clinical outcome database (EAHAD-GTD). Haemophilia : the official journal of the World Federation of Hemophilia 30 (3) (2024)
Radoslaw Kaczmarek, Wolfgang A Miesbach, Margareth Castro Ozelo, Pratima Chowdary
Current and emerging Gene Therapies for Haemophilia A and B. Haemophilia : the official journal of the World Federation of Hemophilia (2024)
Suresh Agarwal, Cedric Hermans, Wolfgang A Miesbach, Flora Peyvandi, Robert F Sidonio, Dane Osmond, Vanessa Newman, Josh Henshaw, Steven W Pipe
Transitioning from emicizumab prophylaxis to valoctocogene roxaparvovec gene therapy: A simulation study for individuals with severe haemophilia A. Haemophilia : the official journal of the World Federation of Hemophilia (2024)
Suresh Agarwal, Cedric Hermans, Wolfgang A Miesbach, Flora Peyvandi, Robert F Sidonio, Dane Osmond, Vanessa Newman, Josh Henshaw, Steven W Pipe
Transitioning from emicizumab prophylaxis to valoctocogene roxaparvovec gene therapy: A simulation study for individuals with severe haemophilia A. Haemophilia : the official journal of the World Federation of Hemophilia 30 (4) (2024)
Wolfgang A Miesbach
Which patients should be considered for gene therapy. Journal of viral hepatitis (2024)
Wolfgang A Miesbach, Manuel D Carcao, Johnny N Mahlangu, Yesim Dargaud, Victor Jimenez-Yuste, Cédric Hermans
Eptacog beta for the management of patients with haemophilia A and B with inhibitors: A European perspective. Haemophilia : the official journal of the World Federation of Hemophilia 30 (2) (2024)
Wolfgang A Miesbach, Manuel D Carcao, Johnny N Mahlangu, Yesim Dargaud, Victor Jimenez-Yuste, Cédric Hermans
Eptacog beta for the management of patients with haemophilia A and B with inhibitors: A European perspective. Haemophilia : the official journal of the World Federation of Hemophilia (2024)
Wolfgang A Miesbach, Nicola Curry, Paul Knöbl, Charles Percy, Rita Santoro, Alvin H Schmaier, Karolin Trautmann-Grill, Kayode Badejo, Jie Chen, Masoud Nouri, Pooja Oberai, Robert Klamroth
Real-world use of recombinant porcine sequence factor VIII in the treatment of acquired hemophilia A: EU PASS. Therapeutic advances in hematology 15 (2024)
Radoslaw Kaczmarek, Wolfgang A Miesbach, Margareth Castro Ozelo, Pratima Chowdary
Current and emerging gene therapies for haemophilia A and B. Haemophilia : the official journal of the World Federation of Hemophilia (2024)
Wolfgang A Miesbach, Ana Boban, Pratima Chowdary, Michael P Makris, Miguel Crato, Victor Jimenez Yuste, Robert Klamroth, Mike Makris, Greta Mulders, Flora Peyvandi
Administration of gene therapy for haemophilia - The hub and spoke model and its regional differences and challenges. Haemophilia : the official journal of the World Federation of Hemophilia 30 (3) (2024)
Wolfgang A Miesbach, Ana Boban, Pratima Chowdary, Michael P Makris, Miguel Crato, Victor Jimenez Yuste, Robert Klamroth, Mike Makris, Greta Mulders, Flora Peyvandi
Administration of gene therapy for haemophilia - The hub and spoke model and its regional differences and challenges. Haemophilia : the official journal of the World Federation of Hemophilia (2024)
Wolfgang A Miesbach, Manuel D Carcao, Johnny N Mahlangu, Yesim Dargaud, Victor Jimenez-Yuste, Cédric Hermans
Eptacog beta for the management of patients with haemophilia A and B with inhibitors: A European perspective. Haemophilia : the official journal of the World Federation of Hemophilia (2024)
Wolfgang A Miesbach, Ana Boban, Pratima Chowdary, Michiel Coppens, Miguel Crato, Victor Jimenez Yuste, Robert Klamroth, Michael P Makris, Greta Mulders, Flora Peyvandi
EAHAD haemophilia gene therapy clinical outcome database (EAHAD-GTD). Haemophilia : the official journal of the World Federation of Hemophilia (2024)
Wolfgang A Miesbach, Nicola Curry, Paul Knöbl, Charles Percy, Rita Santoro, Alvin H Schmaier, Karolin Trautmann-Grill, Kayode Badejo, Jie Chen, Masoud Nouri, Pooja Oberai, Robert Klamroth
Real-world use of recombinant porcine sequence factor VIII in the treatment of acquired hemophilia A: EU PASS. Therapeutic advances in hematology 15 (2024)
Radoslaw Kaczmarek, Wolfgang A Miesbach, Margareth Castro Ozelo, Pratima Chowdary
Current and emerging gene therapies for haemophilia A and B. Haemophilia : the official journal of the World Federation of Hemophilia (2024)
Steven W Pipe, Frank W G Leebeek, Michael Recht, Nigel S Key, Giancarlo Castaman, Wolfgang A Miesbach, Susan Lattimore, Kathelijne Peerlinck, Paul Van der Valk, Michiel Coppens, Peter Kampmann, Karina Meijer, Niamh O'Connell, K John Pasi, Daniel P Hart, Rashid Kazmi, Jan Astermark, Cedric R J R Hermans, Robert Klamroth, Richard Lemons, Nathan Visweshwar, Annette von Drygalski, Guy Young, Shelley E Crary, Miguel Escobar, Esteban Gomez, Rebecca Kruse-Jarres, Doris V Quon, Emily Symington, Michael Wang, Allison P Wheeler, Robert Gut, Ying P Liu, Ricardo E Dolmetsch, David L Cooper, Yanyan Li, Brahm Goldstein, Paul E Monahan
Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B. The New England journal of medicine 388 (8) (2023)
Steven W Pipe, Frank W G Leebeek, Michael Recht, Nigel S Key, Giancarlo Castaman, Wolfgang A Miesbach, Susan Lattimore, Kathelijne Peerlinck, Paul Van der Valk, Michiel Coppens, Peter Kampmann, Karina Meijer, Niamh O'Connell, K John Pasi, Daniel P Hart, Rashid Kazmi, Jan Astermark, Cedric R J R Hermans, Robert Klamroth, Richard Lemons, Nathan Visweshwar, Annette von Drygalski, Guy Young, Shelley E Crary, Miguel Escobar, Esteban Gomez, Rebecca Kruse-Jarres, Doris V Quon, Emily Symington, Michael Wang, Allison P Wheeler, Robert Gut, Ying P Liu, Ricardo E Dolmetsch, David L Cooper, Yanyan Li, Brahm Goldstein, Paul E Monahan
Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B. The New England journal of medicine 388 (8) (2023)
Wolfgang A Miesbach, Annette von Drygalski, Clive A Smith, Krupa Sivamurthy, Karen Pinachyan, Debbie Bensen-Kennedy, Douglass Drelich, Roshni Daniel Kulkarni
The current challenges faced by people with hemophilia B. European journal of haematology (2023)
Wolfgang A Miesbach, Fariba Baghaei, Ana Boban, Pratima Chowdary, Michiel Coppens, Daniel P Hart, Victor Jimenez Yuste, Robert Klamroth, Michael P Makris, Declan Noone, Flora Peyvandi
Gene therapy of hemophilia: Hub centres should be haemophilia centres: A joint publication of EAHAD and EHC. Haemophilia : the official journal of the World Federation of Hemophilia 28 (3) (2022)
Annette von Drygalski, Esteban Gomez, Adam Giermasz, Giancarlo Castaman, Nigel S Key, Susan S Lattimore, Frank W G Leebeek, Wolfgang A Miesbach, Michael Recht, Robert Z Gut, Ricardo Dolmetsch, Paul E Monahan, Sandra Le Quellec, Steven W Pipe
Stable and durable factor IX levels in hemophilia B patients over 3 years post etranacogene dezaparvovec gene therapy. Blood advances (2022)
Wolfgang A Miesbach, Hermann Eichler, Katharina Holstein, Susanne Holzhauer, Robert Klamroth, Ralf Knöfler, Christoph Male, Martin Olivieri, Johannes Oldenburg, Andreas Tiede
Electronic diaries in the management of haemophilia gene therapy: Perspective of an expert group from the German, Austrian and Swiss Society on Thrombosis and Haemostasis (GTH). Haemophilia : the official journal of the World Federation of Hemophilia 28 (2) (2022)
Jennifer Quinn, Kathleen A Delaney, Wing Yen Wong, Wolfgang A Miesbach, Monika Bullinger
Psychometric Validation of the Haemo-QOL-A in Participants with Hemophilia A Treated with Gene Therapy. Patient related outcome measures 13 (2022)
Frank W G Leebeek, Wolfgang A Miesbach
Gene therapy for hemophilia: a review on clinical benefit, limitations, and remaining issues. Blood 138 (11) (2021)
Katja Susanne Häußler, Michael Keese, Christian Friedrich Weber, Christof Geisen, Wolfgang A Miesbach
Prospective Evaluation of the Pre-, Intra-, and Postoperative Kinetics of ADAMTS-13, von Willebrand Factor, and Interleukin-6 in Vascular Surgery. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 26 (2021)
Stephanie Böhmert, Ralf Schubert, Stephan Fichtlscherer, Thomas Hilberg, Sonja Alesci, Wolfgang A Miesbach
Endothelial Function in Patients With Von Willebrand Disease. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 27 (2021)
Wolfgang A Miesbach, Michael Makris
COVID-19: Coagulopathy, Risk of Thrombosis, and the Rationale for Anticoagulation. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 26 (2020)
Wolfgang A Miesbach
Perioperative management for patients with von Willebrand disease: Defining the optimal approach. European journal of haematology 105 (4) (2020)
Wolfgang A Miesbach, Robert Klamroth
The Patient Experience of Gene Therapy for Hemophilia: Qualitative Interviews with Trial Patients. Patient preference and adherence 14 (2020)
Wolfgang A Miesbach, Sabine Kittler, Artur Bauhofer, Christoph Königs, Thomas Becker, László Nemes, Alexander Staus, Jörg Schüttrumpf
Long-term analysis of the benefit of prophylaxis for adult patients with severe or moderate haemophilia A. Haemophilia : the official journal of the World Federation of Hemophilia 26 (3) (2020)
Wolfgang A Miesbach, Brian O'Mahony, Nigel S Key, Michael P Makris
How to discuss gene therapy for haemophilia? A patient and physician perspective. Haemophilia : the official journal of the World Federation of Hemophilia 25 (4) (2019)
Wolfgang A Miesbach, Jan Menne, Martin Bommer, Ulf Schönermarck, Thorsten Feldkamp, Martin Nitschke, Timm H Westhoff, Felix S Seibert, Rainer Woitas, Rui Sousa, Michael Wolf, Stefan Walzer, Björn Schwander
Incidence of acquired thrombotic thrombocytopenic purpura in Germany: a hospital level study. Orphanet journal of rare diseases 14 (1) (2019)
Wolfgang A Miesbach, S-E Reitter-Pfoertner, R Klamroth, F Langer, H-H Wolf, Andreas Tiede, B Siegmund, U Scholz, P R Müller, Hermann Eichler, I Pabinger
Co-morbidities and bleeding in elderly patients with haemophilia-A survey of the German, Austrian and Swiss Society of Thrombosis and Haemostasis Research (GTH). Haemophilia : the official journal of the World Federation of Hemophilia 23 (5) (2017)
Wolfgang A Miesbach, Karina Meijer, Michiel Coppens, Peter Kampmann, Robert Klamroth, Roger Schutgens, Marco Tangelder, Giancarlo Castaman, Joachim Schwäble, Halvard Bonig, Erhard Seifried, Federica Cattaneo, Christian Meyer, Frank W G Leebeek
Gene therapy with adeno-associated virus vector 5-human factor IX in adults with hemophilia B. Blood 131 (9) (2017)